These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4233578)

  • 1. Cardiac catechol O-methyltransferase and monoamine oxidase activity in congestive heart failure.
    Krakoff LR; Buccino RA; Spann JF; De Champlain J
    Am J Physiol; 1968 Sep; 215(3):549-52. PubMed ID: 4233578
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of myocardial catecholamine depletion in cardiac hypertrophy and failure in rabbits.
    Sassa H
    Jpn Circ J; 1971 Apr; 35(4):391-403. PubMed ID: 4253601
    [No Abstract]   [Full Text] [Related]  

  • 3. [The state of the sympathetic-adrenal system in congestive heart failure].
    Korochkin IM; Oganov RG
    Kardiologiia; 1973 Mar; 13(3):140-51. PubMed ID: 4146159
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of norepinephrine contents in cardiac sympathetic neuron during high impulse activity: alterations in monoamine oxidase activity.
    Bhagat BD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():343-56. PubMed ID: 4806659
    [No Abstract]   [Full Text] [Related]  

  • 5. Catechol-O-methyltransferase in autonomic and sensory ganglia of the cat.
    Giacobini E; Kerpel-Fronius S
    Acta Physiol Scand; 1969 Apr; 75(4):523-9. PubMed ID: 5358872
    [No Abstract]   [Full Text] [Related]  

  • 6. Catechol-O-methyl transferase and monoamine oxidase activities in the heart and liver of the embryonic and developing chick.
    Ignarro LJ; Shideman FE
    J Pharmacol Exp Ther; 1968 Jan; 159(1):29-37. PubMed ID: 5643948
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload.
    Kaludercic N; Takimoto E; Nagayama T; Feng N; Lai EW; Bedja D; Chen K; Gabrielson KL; Blakely RD; Shih JC; Pacak K; Kass DA; Di Lisa F; Paolocci N
    Circ Res; 2010 Jan; 106(1):193-202. PubMed ID: 19910579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of noradrenaline and of monoamine oxidase and catechol-O-methyltransferase activity in human foetal heart.
    Gennser G; Rosengren E; von Studnitz W
    Experientia; 1973 May; 29(1):20-2. PubMed ID: 4729439
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of age on monoamine oxidase and catechol-O-methyltransferase in rat tissues.
    Prange AJ; White JE; Lipton MA; Kinkead AM
    Life Sci; 1967 Mar; 6(6):581-6. PubMed ID: 6034176
    [No Abstract]   [Full Text] [Related]  

  • 10. The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1966 Feb; 151(2):273-84. PubMed ID: 5932603
    [No Abstract]   [Full Text] [Related]  

  • 11. Catechol-O-methyltransferase. I. An enzymatic assay for cardiac norepinephrine.
    Nikodijevic B; Daly J; Creveling CR
    Biochem Pharmacol; 1969 Jul; 18(7):1577-84. PubMed ID: 5806102
    [No Abstract]   [Full Text] [Related]  

  • 12. Stability of cardiac monoamine oxidase activity after chemical sympathectomy with 6-hydroxydopamine.
    Lowe MC; Horita A
    Nature; 1970 Oct; 228(5267):175-6. PubMed ID: 5460020
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased monomine oxidase activity during the development of cardiac hypertrophy in the rat.
    de Chaplain J; Krakoff LR; Axelrod J
    Circ Res; 1968 Sep; 23(3):361-9. PubMed ID: 4234068
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of drugs on the accumulation and metabolism of extraneuronal norepinephrine in the rat heart.
    Eisenfeld AJ; Landsberg L; Axelrod J
    J Pharmacol Exp Ther; 1967 Dec; 158(3):378-85. PubMed ID: 4383722
    [No Abstract]   [Full Text] [Related]  

  • 15. Determinants of cardiac noradrenaline depletion in human congestive failure.
    Dequattro V; Nagatsu T; Mendez A; Verska J
    Cardiovasc Res; 1973 May; 7(3):344-50. PubMed ID: 4146654
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations of cardiac sympathetic neurotransmitter activity in congestive heart failure.
    Rutenberg HL; Spann JF
    Am J Cardiol; 1973 Sep; 32(4):472-80. PubMed ID: 4147109
    [No Abstract]   [Full Text] [Related]  

  • 17. ON METABOLISM OF NORADRENALINE IN THE SKIN: ACTIVITY OF CATECHOL-O-METHYL TRANSFERASE AND MONOAMINE OXIDASE.
    MOELLER H
    Acta Derm Venereol; 1963; 43():552-5. PubMed ID: 14088646
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulatory effect of reserpine on monoamine oxidase in guinea pig heart.
    Izumi F; Oka M; Yoshida H; Imaizumi R
    Biochem Pharmacol; 1969 Jul; 18(7):1739-48. PubMed ID: 5806114
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in the activity of the adrenergic nervous system in heart failure.
    Braunwald E
    UCLA Forum Med Sci; 1970; 10():289-94. PubMed ID: 4398780
    [No Abstract]   [Full Text] [Related]  

  • 20. Microsomal monoamine oxidase in sympathetically innervated tissues.
    Stjärne L; Roth RJ; Giarman NJ
    Biochem Pharmacol; 1968 Sep; 17(9):2008-12. PubMed ID: 5693934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.